Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 3

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 4
Chunk 3
---
294 Total assets of businesses held for sale7,004 Insurance and contractholder liabilities1,579 All other liabilities831 Total liabilities of businesses held for sale$2,410 (1) Includes Goodwill of $94 million.

Integration and Transaction-Related CostsIn 2025 and 2024, the Company incurred transaction-related costs associated with the HCSC transaction. These costs incurred consisted primarily of certain projects to separate the Company's systems, products and services; fees for legal, advisory and other professional services; and certain employment-related costs. These costs were $74 million pre-tax ($56 million after-tax) for the three months ended and $290 million pre-tax ($220 million after-tax) for the six months ended June 30, 2025, compared with $63 million pre-tax ($47 million after-tax) for the three months ended and $100 million pre-tax ($76 million after-tax) for the six months ended June 30, 2024.

Note 6 – Earnings Per Share

Basic and diluted earnings per share were computed as follows:

Three Months EndedJune 30, 2025June 30, 2024(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$1,532 $1,532 $1,548 $1,548 Shares:Weighted average266,181 266,181 281,133 281,133 Common stock equivalents1,973 1,973 2,919 2,919 Total shares266,181 1,973 268,154 281,133 2,919 284,052 Earnings per share$5.76 $(0.05)$5.71 $5.51 $(0.06)$5.45 

12

Six Months EndedJune 30, 2025June 30, 2024(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$2,855 $2,855 $1,271 $1,271 Shares:Weighted average268,511 268,511 283,799 283,799 Common stock equivalents2,029 2,029 3,085 3,085 Total shares